PD-L2 expression is correlated with the molecular and clinical features of glioma, and acts as an unfavorable prognostic factor

DOI: 10.1080/2162402X.2018.1541535

Keywords: Glioma, immune response, PD-L2, checkpoint inhibitor

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text